WallStreetZenWallStreetZen

NASDAQ: BCLI
Brainstorm Cell Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Brainstorm Cell Therapeutics earnings were -$11.6M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest BCLI earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$3.0M, up 9.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BCLI reported annual earnings of -$11.6M, with -32.4% growth. The next BCLI earnings date is May 12, 2025.

BCLI earnings history

Current Revenue
$0.0
Current Earnings
-$11.6M
Current Profit Margin
0%

BCLI Return on Equity

Current Company
N/A
Current Industry
-2%
Current Market
34.1%

BCLI undefined

Current Company
-360.7%
Current Industry
-0.4%
BCLI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BCLI announces earnings.

BCLI undefined

Current Company
161.57%
Current Industry
5.9%
BCLI has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BCLI vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BCLI-$11.31M-$11.62MN/A-$2.31
APLM-$53.06M-$53.86MN/A-$52.80
XTLB-$1.78M-$1.78MN/A-$0.30
TRAW-$54.66M-$54.67MN/A-$35.21
INDP-$15.02M-$15.02MN/A-$1.61
View Top Biotech Stocks

BCLI earnings dates

Next earnings date
May 12, 2025

Brainstorm Cell Therapeutics Earnings Reports & History FAQ

What were Brainstorm Cell Therapeutics's earnings last quarter?

On BCLI's earnings call on Invalid Date, Brainstorm Cell Therapeutics (NASDAQ: BCLI) reported Q4 2024 earnings per share (EPS) of -$0.51, up 69.09% year over year. Total BCLI earnings for the quarter were -$2.97 million. In the same quarter last year, Brainstorm Cell Therapeutics's earnings per share (EPS) was -$1.65.

If you're new to stock investing, here's how to buy Brainstorm Cell Therapeutics stock.

When does Brainstorm Cell Therapeutics report earnings?

The next BCLI earnings call is Invalid Date. Add BCLI to your watchlist to be reminded of Brainstorm Cell Therapeutics's next earnings date.

What was BCLI's earnings growth in the past year?

As of Brainstorm Cell Therapeutics's earnings date in Invalid Date, Brainstorm Cell Therapeutics's earnings has grown year over year. BCLI earnings in the past year totalled -$11.62 million.

Is Brainstorm Cell Therapeutics profitable or losing money?

As of the last Brainstorm Cell Therapeutics earnings report, Brainstorm Cell Therapeutics is currently losing money. Brainstorm Cell Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$11.62 million, a 32.39% decrease year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.